HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sunscreen monograph amendment

This article was originally published in The Rose Sheet

Executive Summary

Labeling of sunscreen products introduced after Sept. 1 will need to reflect U.S. Pharmacopeia name changes for four active ingredients, FDA says in technical amendment published in the Federal Register June 20. Changes were proposed by the USP in 2000 based on names endorsed by the U.S. Adopted Names Council, FDA notes. Proposal was accepted in March 2001 and becomes effective Sept. 1. New names include meradimate for menthyl anthranilate; octinoxate for octyl methoxycinnamate; octisalate for octyl salicylate; and ensulizole for phenylbenzimidazole sulfonic acid. Comments on the amendment will be accepted until Aug. 19...

Related Content

Sunscreen Ingredient Name Change Required By Sept. 1
Sunscreen Labeling Amendment Would Disrupt Product Supply – Industry



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts